Ingalls & Snyder LLC Merck & Co., Inc. Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

A detailed history of Ingalls & Snyder LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 243,574 shares of MRK stock, worth $24.2 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

243,574

Previous 246,671 1.26%

Holding current value

$24.2 Million

Previous $30.5 Million 9.42%

% of portfolio

1.08%

Previous 1.31%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $344,231 - $399,420	-3,097 Reduced 1.26%	243,574 $27.7 Million
Q2 2024 Jul 31, 2024	SELL	$123.8 - $132.96 $239,429 - $257,144	-1,934 Reduced 0.78%	246,671 $30.5 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $1.24 Million - $1.45 Million	-10,973 Reduced 4.23%	248,605 $32.8 Million
Q4 2023 Jan 29, 2024	SELL	$100.18 - $109.02 $1.2 Million - $1.31 Million	-12,001 Reduced 4.42%	259,578 $28.3 Million
Q3 2023 Nov 02, 2023	SELL	$102.95 - $114.33 $94,302 - $104,726	-916 Reduced 0.34%	271,579 $28 Million
Q2 2023 Jul 27, 2023	SELL	$108.61 - $118.38 $758,640 - $826,884	-6,985 Reduced 2.5%	272,495 $31.4 Million
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $150,395 - $167,810	-1,461 Reduced 0.52%	279,480 $29.7 Million
Q4 2022 Jan 31, 2023	SELL	$87.44 - $112.11 $650,466 - $833,986	-7,439 Reduced 2.58%	280,941 $31.2 Million
Q3 2022 Oct 21, 2022	SELL	$84.53 - $94.96 $189,347 - $212,710	-2,240 Reduced 0.77%	288,380 $24.8 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $81,987 - $92,936	982 Added 0.34%	290,620 $26.5 Million
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $113,131 - $126,813	1,539 Added 0.53%	289,638 $23.8 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $790,020 - $989,602	-10,930 Reduced 3.66%	288,099 $22.1 Million
Q3 2021 Oct 27, 2021	SELL	$71.68 - $78.83 $1.16 Million - $1.27 Million	-16,129 Reduced 5.12%	299,029 $22.5 Million
Q2 2021 Aug 03, 2021	SELL	$70.31 - $77.77 $269,779 - $298,403	-3,837 Reduced 1.2%	315,158 $24.5 Million
Q1 2021 Apr 21, 2021	BUY	$68.86 - $81.11 $490,214 - $577,422	7,119 Added 2.28%	318,995 $24.6 Million
Q4 2020 Jan 27, 2021	BUY	$71.77 - $79.65 $746,838 - $828,837	10,406 Added 3.45%	311,876 $25.5 Million
Q3 2020 Oct 21, 2020	SELL	$73.18 - $82.95 $107,940 - $122,351	-1,475 Reduced 0.49%	301,470 $25 Million
Q2 2020 Jul 31, 2020	BUY	$70.42 - $80.13 $46,970 - $53,446	667 Added 0.22%	302,945 $23.4 Million
Q1 2020 Apr 22, 2020	BUY	$63.36 - $87.82 $743,276 - $1.03 Million	11,731 Added 4.04%	302,278 $23.3 Million
Q4 2019 Jan 15, 2020	SELL	$77.58 - $87.54 $74,399 - $83,950	-959 Reduced 0.33%	290,547 $26.4 Million
Q3 2019 Oct 16, 2019	SELL	$76.08 - $82.93 $897,287 - $978,076	-11,794 Reduced 3.89%	291,506 $24.5 Million
Q2 2019 Jul 11, 2019	BUY	$69.84 - $81.59 $977 - $1,142	14 Added 0.0%	303,300 $25.4 Million
Q1 2019 Apr 11, 2019	SELL	$69.58 - $79.36 $363,485 - $414,576	-5,224 Reduced 1.69%	303,286 $25.2 Million
Q4 2018 Jan 24, 2019	SELL	$65.24 - $75.71 $465,226 - $539,888	-7,131 Reduced 2.26%	308,510 $23.6 Million
Q3 2018 Oct 24, 2018	SELL	$57.69 - $67.84 $117,976 - $138,732	-2,045 Reduced 0.64%	315,641 $22.4 Million
Q2 2018 Aug 10, 2018	SELL	$50.83 - $59.72 $55,150 - $64,796	-1,085 Reduced 0.34%	317,686 $19.3 Million
Q1 2018 Apr 17, 2018	SELL	$50.96 - $59.23 $1.28 Million - $1.49 Million	-25,172 Reduced 7.32%	318,771 $17.4 Million
Q4 2017 Jan 19, 2018	SELL	$51.62 - $61.64 $583,667 - $696,963	-11,307 Reduced 3.18%	343,943 $19.4 Million
Q3 2017 Oct 20, 2017	BUY	$58.67 - $63.13 $20.8 Million - $22.4 Million	355,250	355,250 $22.7 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Merck & Co., Inc. Transaction History